TP53 and cervical cancer: The promoter of miR-23b is methylated in cervical cancer [60] and has a consensus p53-binding site, therefore p53 diminish by the presence of HR-HPV16-E6 oncoprotein induces a down-regulation of miR-23b and an increased expression of uPA via 3′UTR mRNA binding [61].